Ibc Pharmaceuticals Private Limited

Ibc Pharmaceuticals Private Limited - chemicals and materials in Thane, Maharashtra, India. FY 2026 financials & compliance.
CIN U24239MH2011PTC215791 Incorporated 05 April 2011 ROC Mumbai HQ Thane, Maharashtra, India
Active Private Limited Company chemicals and materials
Revenue · FY 2025
₹94 Lakh
▲ 37% YoY
Net profit · FY 2025
₹16,042
Net margin 0.2%
EBITDA · FY 2025
₹10.48 Lakh
EBITDA margin 11.2%
Authorised capital
₹11 Lakh
Registered with MCA
Paid-up capital
₹4.48 Lakh
Issued & subscribed
Open charges
₹2 Cr
Secured borrowings
Company age
15 yrs
Est. 2011
Directors on board
5
As per MCA filings

About Ibc Pharmaceuticals Private Limited

Data last updated:

Ibc Pharmaceuticals Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the specialty chemicals segment of the chemicals and materials sector. It was incorporated on 05 April 2011 and has been in existence for over 15 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH2011PTC215791. Its GSTIN is 27AACCI5767R1ZP (Maharashtra). The company holds 4 GST registrations, of which 2 are active.

The company has an authorised share capital of ₹11 Lakh and a paid-up capital of ₹4.48 Lakh. It is led by directors including Deepak Virbhadra Kabbur and Kranthikiran Siddappa.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Thane, Maharashtra.

As per the financials filed for FY 2025, the company reported a revenue of ₹94 Lakh, a growth of 37% compared to the previous year. For the same year it recorded a net profit of ₹16,042 (net margin 0.2%) and EBITDA of ₹10.48 Lakh (EBITDA margin 11.2%). Revenue has grown at a compounded annual rate (CAGR) of 112% over three years and 20% over five years.

As per MCA filings, the company has open charges of ₹2 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24239MH2011PTC215791
Registration Number 215791
Incorporation Date 05 April 2011
ROC Mumbai
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

Contact details

Ibc Pharmaceuticals Private Limited's registered office is in Thane, Maharashtra. Its e-mail address is in the company report.

  • Email
  • Registered Address
    Office No 705 And 706 Arihant Aura, Plot No.13/1 Ttc Industrial Area Turbhe, Thane, Maharashtra, India – 400705
  • Industry
    Chemicals and Materials, Specialty Chemicals

To see the full contact details of Ibc Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Ibc Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Ibc Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GWholesale and retail trade; repair of motor vehicles and motorcycles45Wholesale and retail trade and repair of motor vehicles and motorcycles

To see the full business activity and turnover split of Ibc Pharmaceuticals Private Limited, buy the company report.

Financials of Ibc Pharmaceuticals Private Limited

FY 2025 filings available

Ibc Pharmaceuticals Private Limited reported revenue of ₹94 Lakh (up 37% YoY) for FY 2025.

Revenue · FY 2025
₹94 Lakh ▲ 37%
Net profit · FY 2025
₹16,042 margin 0.2%
EBITDA · FY 2025
₹10.48 Lakh margin 11.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 37%
3 years · compounded
▲ 112%
5 years · compounded
▲ 20%
EBITDA CAGR growth
1 year
▼ 34%
3 years · compounded
▲ 65%
5 years · compounded
▲ 5%

Revenue has grown at a compounded annual rate (CAGR) of 20% over five years, including 37% growth in the latest year. EBITDA fell 34% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹10.48 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹16,042
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin11.2%
Net Profit Margin0.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Ibc Pharmaceuticals Private Limited, buy the company report.

Board of directors of Ibc Pharmaceuticals Private Limited

Ibc Pharmaceuticals has 5 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Deepak Virbhadra KabburDirector29 Nov 20178 Years 11 MonthsCurrent
Kranthikiran SiddappaDirector29 Nov 20178 Years 11 MonthsCurrent
Ravindranath Tagore TalasilaDirector29 Nov 20178 Years 11 MonthsCurrent
Rajeev Virbhadra KabburDirector14 Feb 20206 Years 9 MonthsCurrent
Shubham Suresh MishraDirector05 Apr 201115 Years 7 MonthsCurrent

Auditor

Ibc Pharmaceuticals Private Limited is audited by AKASAM & ASSOCIATES for the financial year 2023.

Auditor firmFinancial yearFirm registration number
AKASAM & ASSOCIATESFY 2023005832S

Shareholding

The shareholding of Ibc Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Public
Others

To see the full shareholding pattern of Ibc Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹2 Cr
Satisfied charges
None
Breakdown by lending institutions
State Bank of India₹2.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
14 Nov 2024101026770State Bank of India₹2 CrOpen

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Ibc Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Ibc Pharmaceuticals has 4 GST registrations: 2 active and 2 cancelled or inactive.

Total GSTINs
4
Active
2
Cancelled / inactive
2
GSTINStateStatusRegistered on
27AACCI5767R1ZPMaharashtraActive01 Jul 2017
36AACCI5767R2ZPTelanganaActive01 Jul 2017

To see the full GST registrations and return filing status of Ibc Pharmaceuticals Private Limited, buy the company report.

Recent activity

Ibc Pharmaceuticals Private Limited has 11 board changes on record since 2011: 5 appointments and 6 cessations. The latest: Rajeev Virbhadra Kabbur ceased to be Additional Director on 31 Dec 2020.

AGM
Ibc Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Ibc Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge with State Bank Of India amounted to Rs. 200.00 Lakh with Charge ID 101026770 was registered on 14 Nov 2024.
Ceased
Rajeev Virbhadra Kabbur ceased to be Additional Director.
Appointed
Rajeev Virbhadra Kabbur was appointed as Director.
Ceased
Deepak Virbhadra Kabbur ceased to be Additional Director.
Ceased
Kranthikiran Siddappa ceased to be Additional Director.
Ceased
Ravindranath Tagore Talasila ceased to be Additional Director.
Ceased
Vijayalakshmi Mishra ceased to be Director.
Appointed
Deepak Virbhadra Kabbur was appointed as Director.
Appointed
Kranthikiran Siddappa was appointed as Director.
Appointed
Ravindranath Tagore Talasila was appointed as Director.

3 earlier events are in the company report.

Frequently asked questions

Ibc Pharmaceuticals is an active private limited company based in Thane, Maharashtra, India. The company works in specialty chemicals, within the chemicals and materials industry. It was incorporated on 05 April 2011 (15+ years old) and is registered under CIN U24239MH2011PTC215791.

Ibc Pharmaceuticals has 5 current directors:

The latest financial statements of Ibc Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Ibc Pharmaceuticals is 27AACCI5767R1ZP, registered in Maharashtra. The company has 4 GST registrations in all, of which 2 are active and 2 are cancelled or inactive. Other active GSTINs include 36AACCI5767R2ZP (Telangana).

The CIN (Corporate Identification Number) of Ibc Pharmaceuticals is U24239MH2011PTC215791. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Ibc Pharmaceuticals was incorporated on 05 April 2011, making it 15+ years old. It is registered with the Registrar of Companies, Mumbai.

Rajeev Virbhadra Kabbur ceased to be Additional Director on 31 Dec 2020. Rajeev Virbhadra Kabbur was appointed as Director on 14 Feb 2020. Deepak Virbhadra Kabbur ceased to be Additional Director on 30 Sep 2019. Ibc Pharmaceuticals has 11 board changes on record in total.

The registered office of Ibc Pharmaceuticals is at Office No 705 And 706 Arihant Aura, Plot No.131 Ttc Industrial Area Turbhe, Thane, Maharashtra, India – 400705.

Ibc Pharmaceuticals operates in the chemicals and materials industry, in the specialty chemicals segment.

Ibc Pharmaceuticals has open charges of ₹2 Cr and no satisfied charges on record as per latest MCA filings.